Ding Ding

Ding Ding is an experienced pharmaceutical professional specializing in clinical pharmacokinetics and regulatory submissions. With a solid background that includes roles at DuPont Pharmaceuticals and Pfizer Inc, Ding has demonstrated expertise in bioanalytical method development, data analysis, and authoring regulatory study reports. Ding has consistently achieved excellence in managing Toxicokinetic studies and has received multiple awards for outstanding performance at Pfizer. Ding holds an M.S. in Regulatory Affairs, Quality Assurance, and Chemistry from Temple University, complemented by degrees in Chemistry from Peking University and The Catholic University of America.